lestaurtinib has been researched along with 7-hydroxystaurosporine in 1 studies
| Studies (lestaurtinib) | Trials (lestaurtinib) | Recent Studies (post-2010) (lestaurtinib) | Studies (7-hydroxystaurosporine) | Trials (7-hydroxystaurosporine) | Recent Studies (post-2010) (7-hydroxystaurosporine) |
|---|---|---|---|---|---|
| 124 | 12 | 63 | 322 | 20 | 51 |
| Protein | Taxonomy | lestaurtinib (IC50) | 7-hydroxystaurosporine (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Chk1 | Homo sapiens (human) | 0.0099 | |
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 0.0055 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asami, Y; Crump, A; Ōmura, S | 1 |
1 review(s) available for lestaurtinib and 7-hydroxystaurosporine
| Article | Year |
|---|---|
Staurosporine: new lease of life for parent compound of today's novel and highly successful anti-cancer drugs.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Carbazoles; Drug Discovery; Furans; Humans; Imatinib Mesylate; Neoplasms; Protein Kinase Inhibitors; Staurosporine | 2018 |